- Report
- September 2022
- 159 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- December 2022
- 112 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- August 2022
- 119 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- June 2021
- 87 Pages
Global
€21268EUR$22,000USD£18,280GBP
- Drug Pipelines
- February 2019
- 300 Pages
Global
From €21268EUR$22,000USD£18,280GBP
- Report
- May 2020
- 218 Pages
Global
From €10629EUR$10,995USD£9,136GBP
- Report
- April 2018
Global
From €967EUR$1,000USD£831GBP
- Report
- November 2023
- 111 Pages
China
From €1740EUR$1,800USD£1,496GBP
- Report
- June 2023
- 87 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Report
- October 2023
- 82 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Report
- April 2024
- 50 Pages
Global
From €2562EUR$2,650USD£2,202GBP
- Report
- November 2023
- 239 Pages
China
From €3867EUR$4,000USD£3,324GBP
- Report
- November 2021
- 844 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- November 2021
- 575 Pages
Global
From €3867EUR$4,000USD£3,324GBP
- Report
- March 2023
- 300 Pages
Global
From €5539EUR$5,730USD£4,761GBP
- Report
- April 2023
- 147 Pages
Global
From €5799EUR$5,999USD£4,985GBP
- Report
- February 2022
- 111 Pages
Global
From €4350EUR$4,500USD£3,739GBP
Memantine is a drug used to treat symptoms of Alzheimer's disease and other forms of dementia. It is classified as an NMDA receptor antagonist, which works by blocking the action of a neurotransmitter called glutamate. This helps to reduce the symptoms of dementia, such as memory loss, confusion, and difficulty with language. Memantine is also used to treat Parkinson's disease, Huntington's disease, and multiple sclerosis.
Memantine is a relatively new drug, having been approved by the FDA in 2003. It is available in both oral and intravenous forms, and is typically prescribed in combination with other drugs. It is generally well-tolerated, with few side effects.
The memantine market is a growing one, with a number of companies offering products. These include Novartis, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Other companies, such as Actavis, Lupin, and Dr. Reddy's Laboratories, also offer generic versions of the drug. Show Less Read more